Stock Information
Myriad Genetics Inc (MYGN)
Ticker Symbol: MYGN
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $442.77 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -3.9529
Revenue (TTM): $8.82 M
Dividend Yield: N/A%
ROE: -79.81%
Latest News
-
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
Thu, Apr 16, 2026 9:15 AM
-
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
Tue, Apr 14, 2026 9:21 AM
-
Myriad Genetics Receives Japan Approval For MyChoice Test For Prostate Cancer Patients
Tue, Apr 14, 2026 9:18 AM
Key Financials
Financial data not available
